Previous Close | 32.63 |
1-Year Change | -8.6% |
6-Months Change | -5.01% |
3-Months Change | -10.58% |
Moving Avg (50d) | 36.461 |
Moving Avg (200d) | 37.457 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 16.5B |
Beta (3-Years) | 0.57 |
Revenue Growth (ttm) | 6.88% |
Net Profit Margin (ttm) | 16.81% |
Return On Assets (ttm) | 8.46% |
EPS (ttm) | 5.11 |
PE Ratio (ttm) | 6.39 |
Dividend Yield | 3.56% |
Asset Description: | Baxter International Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-08 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
31.977 | 30.999 | 30.346 | 29.367 | 27.736 | 26.104 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins... Wikipedia